Unprecedented global progress in fighting malaria since 2000 is at stake unless countries redouble their efforts, according to the latest figures released by the World Health Organization (WHO) today.
The World Malaria Report 2017 shows fragile and uneven progress in global efforts against malaria, an entirely preventable and treatable disease, which puts half the world’s population at risk and costs a child’s life every two minutes.
According to the report, malaria-related cases and deaths worldwide stood at 216 million and 445,000 respectively, in 2016, a flatline in the tremendous gains of the past 16 years in the fight against malaria. The report sends a clear warning that progress could be in jeopardy and resurgence is on the rise.
“Limiting malaria’s devastating impact on families, communities and countries has been one of the global health success stories of our time. Since 2000, thanks to significant investment, strong political leadership and new tools, we have saved nearly 7 million lives from this deadly disease. Today, we have an opportunity to save millions more by renewing our resolve and commitment, as a global community, to end malaria for good,” said Dr Winnie Mpanju-Shumbusho, Chair of the Board of the RBM Partnership to End Malaria.
Read the full press release in[English], [Portuguese] and [French]
The Country and Regional Support Partner Committee (CRSPC) of the RBM Partnership to End Malaria has supported the roll out of the updated programmatic and financial gap analyses as part of the broader support to countries in the development of their Global Fund malaria applications for the period 2018-2020. This moving summary includes the data from 35 countries that have finalised their grant making process, and additional updates will be provided as more final gap analyses become available.
For the 35 countries with finalised gap analyses, countries estimate that almost US$10 billion is required over the next three years to fully implement their national strategic plans. Countries estimate that approximately 48% of the plans are funded, leaving a gap of US$5.2 billion. However, when countries estimate the requirements for the delivery of the essential interventions; vector control (LLINs or IRS), diagnosis and treatment, the estimated need is US$6 billion, of which 76% is funded, with a gap of US$1.5 billion.
The gaps in Nigeria constitute around 46% of the gaps in essential commodities and their delivery over the next three years. Given Nigeria constitutes an estimated 30% of malaria deaths and 27% of cases, filling these gaps will be essential. A number of high-burden countries have gaps and will fail to sustain coverage of vector control, especially in 2020 if the funding gaps are not filled.
Not surprisingly, the majority of the gaps are in 2020, as countries have worked to frontload their resources to avoid as much as possible gaps in the near future. The CRSPC will focus efforts on ensuring these gaps are filled through support to advocacy and resource mobilization at county level, whilst supporting countries to address bottlenecks during grant implementation.
The programmatic gap analysis outlines the programmatic requirement needed to fully implement the strategic plan of a national malaria control programme over a specified time period. It identifies funding needs derived from national strategic plan targets, the components already funded, and highlights outstanding financial gaps for which additional funding is required.
The CRSPC supported gap analysis is based on the national strategic plans and covers key malaria interventions including vector control (Long Lasting Insecticidal Nets (LLINs) and Indoor Residual Spraying (IRS)), case management (diagnostic testing and treatment), preventive chemotherapy (Intermittent preventive treatment in pregnancy (IPTp), and seasonal malaria chemoprevention (SMC)).
Needs and funding required for the supportive activities needed to effectively deploy and monitor these interventions such as management capacity, training, behavior change communication, surveillance and monitoring and evaluation are captured in the overall needs summary. The CRSPC gap analysis follows an evidence-based approach to planning and programming based upon the targets and strategies outlined in the malaria national strategic plan. The Programmatic Gap analysis is an integral part of the programme planning and implementation cycle and is not a stand-alone exercise and is updated regularly when new information becomes available.
GAPS analysis 1GAPS analysis 2
The RBM Partnership to End Malaria warmly congratulates Peter Sands, a former chief executive of Standard Chartered Bank, on his selection as the next Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, announced earlier today in Geneva.
Dr Kesete Admasu, RBM Partnership CEO and Member of the Global Fund Board, commented: “On behalf of the RBM Partnership, I am delighted to welcome Peter Sands as the new Executive Director of the Global Fund. Sustained and increased financing is essential for putting an end to deadly diseases, including malaria. Accounting for nearly half of global malaria financing, the Global Fund is a key mechanism that allows funds to flow to those who need them most—and malaria has proven to be one of the best investments in public health. Most importantly, the Global Fund shares the RBM’s vision of working in partnership with endemic countries, the private sector, civil society, research and academic institutions to achieve more, together. We look forward to working with Mr Sands in his new role and assure him of the steadfast support of the more than 500 RBM Partners worldwide.”
Born in the United Kingdom, Sands served as Chief Executive Officer of Standard Chartered PLC from 2006 to 2015, having joined the bank in 2002 as Group Finance Director. He led Standard Chartered’s transformation into one of the world’s leading international banks, focusing its corporate responsibility initiatives on health issues, including avoidable blindness, AIDS and malaria. Sands served on the board of the Global Business Coalition on AIDS, Tuberculosis and Malaria and was Lead Non-Executive Director on the board of the United Kingdom’s Department of Health.
After stepping down from the bank in 2015, Sands deployed his skills and experience in international finance on global health. Sands served as Chairman of the U.S. National Academy of Medicine’s Commission on a Global Health Risk Framework for the Future, which published the influential report on pandemics entitled The Neglected Dimension of Global Security: a Framework to Counter Infectious Disease Outbreaks. He currently serves as Chairman of the World Bank’s International Working Group on Financing Pandemic Preparedness and holds a number of research positions.
As new Executive Director, Sands will oversee and guide the implementation of the Global Fund’s 2017-2022 strategy, designed to maximize impact against HIV, TB and malaria and build resilient and sustainable systems for health.
More information: https://www.theglobalfund.org/en/news/2017-11-14-global-fund-appoints-peter-sands-as-executive-director/
The RBM Partnership to End Malaria commends all partners and committees, especially Country and Regional Support Partner Committee (CRSPC), for supporting countries in mobilising resources through the Global Fund to Fight AIDS, Tuberculosis, and Malaria. Thanks to RBM’s technical support, over 50 countries have submitted successful applications to the Global Fund, thus securing approximately US$3 billion for malaria control and elimination.
By the end of the first three application windows in August 2017, over 95% of malaria applications (55) have been submitted and reviewed by the Technical Review Panel (TRP). Only nine country proposals were outstanding, with five scheduled for submission in the fourth window in February 2018. Over 90% of the malaria applications were submitted in the first two windows, allowing sufficient time for countries to prioritise grant-making efforts to prevent any break in implementation in 2018. Of the 55 country applications, 95% have gone through to grant making, with just three in iteration.
The RBM Partnership has supported countries through organising orientation and mock TRP workshops that played a key role in the success of their applications. Two rounds of orientation and four rounds of mock TRPs in which 54 countries participated were held to review country draft applications. Additionally, RBM Partnership has been supporting countries during grant-making process to accelerate grant signature. In total, 29 countries have fully completed all the documentation required for grant-making. 58% of window 1 and 2 countries have completed the grant-making process and will be on track to implement their grants before the current ones expire at the end of the year.
In working towards realising its vision of a malaria-free world, the RBM Partnership to End Malaria engages partners, decision-makers and influencers to help drive political will and mobilise resources that will accelerate global, regional and national efforts to end malaria.
The RBM Partnership is seeking agency support to:
Flesh out and implement a comprehensive 2018 communications plan that will drive the overarching RBM Partnership’s 2018-2020 Strategic Plan goals and reinforce efforts of country/regional support and advocacy/resource mobilisation Partner Committees.
Elevate malaria on the global agenda and build momentum amongst leaders and influencers to end it for good.
Sustain momentum and support funding mobilisation for regional and national elimination efforts.
Develop effective and consistent messaging that supports all levels of communication from global influencers, regional and national decision-makers to malaria-affected communities.
Engage RBM Partners in actively supporting the RBM Partnership brand and activities.
Do you have what it takes to help us achieve these objectives? Interested agencies are invited to submit their bids via the UNOPS eSourcing system before 21 November 12:00 noon Geneva time.
More information: https://www.ungm.org/Public/Notice/63889